Massachusetts Medicaid Lifts Paroxetine Prior Authorization For Children
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline’s Paxil and Paxil CR continue to require prior authorization under the program. Lifting of prior authorization for pediatric use of paroxetine comes despite FDA’s request that a “black box” warning on pediatric suicidality be added to antidepressant labeling.